Petit wrap up. Said he wanted to talk briefly about market cap. Said they stopped road shows a couple years ago because stock got ahead of itself. Although he feels it's up to investors to value stock he believes where company is now that stock could be valued at 10X revenue. That would put stock near $20 if my math is right. And in their 5 year strategic plan he said MDXG's revenues are expected to be SEVERAL times what they are today. Math gets interesting. Poor Suraj. Poor candy. Poor chubby reporter in Oklahoma.
THey had $150 million on their balance sheet on their 10Q for Q2. No update on cash today as they won't update any financial info until their Q3 report.
rebecca, we all know you are that chubby "reporter" from Oklahoma who gets paid by Streetsweeper which has mob ties according to the United States Government. We all know your game. Good luck with your short, which isn't going very well for you. It's going to get worse for you. A lot worse.
by halloweencandy2013•May 28, 2014 6:37 PM
get their clients in at higher prices and hype to get them out. shorted more at $5.90 this morning. we'll continue to short more on any strength. sell sell sell
by halloweencandy2013•Apr 15, 2014 12:52 PM
here comes the high $4's and then the low $4's will soon follow. shorting more at these levels. we will cover in the mid $2's
@adamfeuerstein: $GALE CEO Mark Ahn has been fired by the company’s board of directors, a source close to the co. tells me. Public announcement tomorrow.
Halloweencandy2013 • May 23, 2014 12:57 PM
really? i think we'll continue to short more at these levels. thanks pete!
Price on May 23 was $5.58. How's that working for you Candy?
Halloweencandy2013 • May 21, 2014 1:15 PM
really doc. just like the secondary was 5x oversubscribed. the word is spreading. i was told 3 months ago to short this stock at anything above 5 dollars. i know many brokers who are shorting this for individual clients. stay strong and loyal to pete and lose everything.
Looks like you got bad advice about shorting above $5? Maybe you need to find advisors other than the chubby lady from Oklahoma and the mobsters from street sweeper?
Halloweencandy2013 • Apr 29, 2014 12:16 PM
good idea. start shorting. wait for pete's trial
What happened to the trial Candy?
by halloweencandy2013 • Mar 22, 2014 10:09 PM
watch and learn. you're going to lose a lot of money. the SEC has a strong case and the reputation of MiMedx and all of their management team is in question. big money has turned and will drive this stock down. institutions that bought the secondary are now selling. you fell in love and Pete just cheated on you and other shareholders. Less
Where is the strong case Candy?
halloweencandy2013 • Jan 20, 2014 12:39 PM
I wouldn't increase my holdings if I were you! The company is a scam!
Yeah a real scam Candy, sales rocketing every quarter and they pulled the owl right over the eyes of Medtronic and Zimmer
LOL. This is an old suit and nothing will come of it as I just explained on the MDXG board. FWIW, same thing with OSIR's suit. These are ambulance chasers looking for a payoff to go away.
bu3800, are you suggesting the chubby reporter from Oklahoma will re-appear? :-)
doc,I suspect the shorts here are pretty clueless and that it will end badly for them. Very badly.
Hospitals, doctors, Medtronic, Zimmer and former OSIR distributors choosing EpiFix 3 to 1 over Grafix. Buy, buy, buy.
Cez#$%$ knows nothing about the company, in either of the IDs he uses here, this one or halloween. They are the same guy. On the other hand, I do know and talk to sales reps and they couldn't be happier...chomping at the bit to get the go ahead on the injectable.
how bout, this is NOT a common situation, not a case where a non approved drug is going to file for a BLA and asks for a transition letter to sell it while it files a BLA .It is a drug that the company justififiably has been selling for years based on 360,which the FDA was well aware of, and then out of the blue and inexplicably changes its mind and wants a BLA, a drug that has been injected tens of thousands of times with no adverse results and proven effectiveness, including injected thousands of times by US GOVERNMENT doctors. So this fact patters does not lend itself to an attempt to find precedent.
The only thing you need to worry about (and worry is the wrong word) is that the company continues to report great numbers and growth prospects to maximize its sale price next year.
will put link on SW forum but here is the section
TLSR: What are some of your favorite medical device companies?
WP: In the wound care space, my favorite company is MiMedx Group Inc. (MDXG:OTCBB), which is providing better, faster and cheaper technology compared to current therapies.
TLSR: Let's switch to wound healing. Tell me about MiMedx's amniotic membrane-based technology.
WP: Regarding advanced wound care, a patient will present with a diabetic foot ulcer or venous leg ulcer. These are different than standard wounds, with blood flow to the extremities being an issue. The continuum of care begins with a standard bandage. If that doesn't work, the next step is a more advanced bandage: silver coated or honey coated. If those don't work, more advanced technologies are required and can include negative pressure wound therapy, hyperbaric oxygen chambers, and advanced wound-covering technologies. MiMedx is focused on advanced wound-covering/regeneration technologies in the skin substitute market.
MiMedx uses amniotic tissue derived from live birth placenta. Published clinical data demonstrated a 92% wound-healing rate in diabetic foot ulcers. Patients typically require two or three grafts, with a total cost per patient of $2-3K.
Since commercializing its products over the last several years, MiMedx has grown significantly and has taken a significant portion of market share. The products work well, reimbursement is in place and distribution continues to ramp to properly address the U.S. market.
market, I believe MDXG has 5 analysts covering the company. How many does OSIR have?